Clinical Trial Update: Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial [NA]

View source ↗

Summary

Open-label demonstration trial comparing Glycosade (cornstarch) to gastrostomy tube–dextrose infusion for overnight euglycemia control in children with glycogen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glycogen Storage Disease Type
• Hypoglycemia

Drugs mentioned

• Gastrostomy Tube-Dextrose Infusion
• Glycosade (cornstarch)

Snippet

Sponsor: University of Manitoba | Conditions: Glycogen Storage Disorder Type 1, Hypoglycemia | NA | Status: COMPLETED